Use: Cerotex is a nootropic agent and a central cholinostimulator, containing 40.5% metabolically protected choline. Metabolic protection promotes the release of choline in the brain. The drug ensures the synthesis of acetylcholine and phosphatidylcholine in neuronal membranes, improves blood flow, and enhances metabolic processes in the central nervous system, activating the reticular formation. It increases the linear blood flow velocity on the side of traumatic brain injury, contributes to the normalization of spatiotemporal characteristics of spontaneous bioelectrical brain activity, regression of focal neurological symptoms, and restoration of consciousness. Cerotex has a positive effect on the cognitive and behavioral responses of patients with cerebrovascular diseases, such as discirculatory encephalopathy and residual effects of cerebrovascular accident. The drug also has a prophylactic and corrective effect on the pathogenetic factors of involutional psycho-organic syndrome, changes the phospholipid composition of neuronal membranes, participates in the synthesis of phosphatidylcholine (a membrane phospholipid), and improves the plasticity of neuronal membranes. It stimulates dose-dependent acetylcholine release under physiological conditions, improves synaptic transmission and receptor function. Contraindications: - Hypersensitivity to the components of the drug. - Acute stage of hemorrhagic stroke. - Pregnancy. - Lactation period. - Children and adolescents under 18 years of age (due to lack of data). Storage: Do not use after the expiration date. The drug is dispensed by prescription. More detailed storage conditions (e.g., temperature regime, protection from light) were not specified in the found sources for this product.